World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen
MarketsHeard on the StreetAs AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be the middlemen negotiating and dispensing the ...
MarketsHeard on the StreetAs AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be the middlemen negotiating and dispensing the ...
MarketsHeard on the StreetBig Pharma has taken much of the heat for sky-high insulin prices, but scrutiny could soon shift ...
MarketsFinancial RegulationProsecutors and regulators say healthcare company executive tipped friend to company’s drug approval
An activist challenge starts a discussion of how the consumer-goods giant might break up.
MarketsHeard on the StreetCompany’s decision to price its Covid-19 vaccine at $110-$130 per dose seeks to make up for lower ...
U.S. stock indexes pared losses after being on course for a fifth consecutive down day as investors weighed interest rates ...
Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth ...
Like many patients suffering from amyotrophic lateral sclerosis, or ALS—also known as Lou Gehrig’s disease—Layne Oliff didn’t have any time ...
Listen to article(2 minutes)Defense contractor L3Harris Technologies Inc. is near a deal to buy a military-communications business from satellite specialist ...
Under ordinary circumstances, the pharma industry would look like a bad place to park your money right now. The government is ...